ALLSKIN | MED Clinical Symposium 2026
Monday, 14th September 2026
The ALLSKIN | MED Clinical Symposium 2026 is an exclusive educational event bringing together leading experts in dermatology, aesthetic medicine and skin health at the prestigious Royal Society of Medicine.
Designed for both new and established ALLSKIN | MED clinic partners, the Clinical Symposium will bring together leading clinicians and industry experts to explore how the clinic-exclusive, medical-grade ALLSKIN | MED range can support treatment protocols, improve patient outcomes, and promote long-term skin health.
All sessions draw on the latest innovations and clinical evidence from Cantabria Labs, Science that Cares. Attendees will leave with the evidence-based skincare knowledge to improve treatment efficacy in their clinic.
Confirmed Speakers
Explore the research history and clinical evidence supporting SCA PRO growth factor technology. Learn how SCA PRO can be incorporated into treatment protocols to enhance treatment outcomes, accelerate recovery and support skin regeneration across a range of aesthetic procedures.
Explore the innovation behind RetinDuo®, Cantabria Labs’ dual-retinoid technology. Discover how enhanced bioavailability, dual-action activity and advanced delivery systems optimise retinoid performance, improve tolerance and deliver superior results across multiple indications, including hyperpigmentation, photodamage, ageing and acne-prone skin.
Understand how skin biology, barrier integrity and pre-treatment preparation influence treatment tolerance, patient outcomes and long-term skin health. Learn how ALLSKIN | MED treatment plans can support optimal treatment readiness and results.
Learn how ASPA-Fernblock® technology delivers full-spectrum protection against UVA, UVB, Visible Light and Infrared-A while supporting skin repair, resilience and long-term skin health through OPTI-D activity.
Discover how to use clinic performance data, patient insights and treatment trends to create more effective marketing, build credibility and attract the right patients. The session will also explore how emerging AI technologies are beginning to support clinic growth through improved efficiency, content planning and patient communication.
Gain exclusive insight into upcoming product developments, emerging technologies and future innovations from ALLSKIN | MED and Cantabria Labs. Be among the first to discover what’s next in evidence-based skincare and how these innovations will support future clinical practice.
Why Attend?
Who Should Attend?
This event is for medical aesthetic clinics, whether you are new to ALLSKIN | MED or an established clinic partner. If you and your team are committed to delivering the best possible skin health outcomes for your patients, this is the event for you.
Event Details
Date: Monday, 14 September 2026
Time: 2:00 PM – 5:00 PM (Registration & arrival from 1:45 PM)
Venue: Royal Society of Medicine, 1 Wimpole Street, London, W1G 0AE
Ticket Price: £60 + VAT
Secure Your Place
Due to the nature of the venue, spaces are very strictly limited, and will be allocated on a first come, first served basis, so don’t delay and secure your place early to avoid missing out.
About Your Speakers
María Vitale-Villarejo, M.D. – Currently the Medical Manager Dermatology at Cantabria Labs, a Spanish-based pharmaceutical company specialized in dermatology and medical nutrition.
Graduate in Dermatology from the University of Buenos Aires and trained in the Dermatology Department of the University Clinic Hospital of Buenos Aires, she also participated in internships at the University of Pennsylvania School of Medicine and the Cleveland Clinic of Florida. She is the author of numerous publications and is a regular speaker at international dermatology and medical congresses, specialising photoprotection and photoaging. Dr. Vitale-Villarejo is a member of the AAD (American Academy of Dermatology, SAD (Argentina Dermatology Society) and SOCS (Skin of Color Society).
Dr Catherine Fairris BSc (Hons), MB ChB, MRCP, MSc (Aesth), PG Cert – Leading aesthetic Doctor, best known for her specialist interest in evidence based minimally invasive aesthetic treatments and skincare. With a passion for promoting patient safety in aesthetics, Dr Fairris has established themselves as a thought leader in regulation in aesthetics, offering fresh insights and solutions to promoting patient safety and improving regulation in aesthetic medicine.
She is a Member of the Royal College of Physicians and served as President of the British College of Aesthetic Medicine (BCAM) 24-25, an organisation for doctors and dentists practising in the field. Prior to her presidency, she was a trustee responsible for education and events.
With extensive experience in injectable treatments, Dr Fairris has also published academic work on complications management, a particular area of interest that she continues to pursue. She believes aesthetic medicine is a distinct medical discipline and is committed to patient-centred care, ensuring that clinical needs remain at the core of every treatment plan.
Dr Paris Acharya (BDS Hons, MBChB, MFDS, MRCS Ed) – A London-based doctor, former maxillofacial surgeon and founder of Clinic Dr Paris, a discreet, doctor-led destination in Marylebone specialising in regenerative aesthetics and longevity medicine.
Dual-qualified in medicine and dentistry, her work is underpinned by a deep understanding of skin biology, anatomy and systemic health. She is renowned for her refined, light-touch approach to injectables and regenerative treatments, guided by a signature philosophy: restore, support and enhance, never over-correct.
Her clinical focus centres on long-term skin health, with particular emphasis on barrier integrity, inflammation control and skin preparation as the foundation for optimal outcomes. She attracts a discerning patient who values subtle, natural results and a highly personalised approach.
As a Key Opinion Leader and International Faculty member for ALLSKIN | MED, Dr Paris is a leading voice in “skin biology before intervention,” educating clinicians globally on the importance of preparation to maximise treatment efficacy, safety and longevity.
Roger Bloxham BSc (Hons), FRSB – Roger has more than 35 years of experience in the pharmaceutical, medical device, and dermocosmetic industries. For over 20 years, his work has centred on dermatology and dermocosmetics as Founder, Owner and Managing Director of Ferndale Pharma UK, where he also leads the company’s scientific and technical direction.
With a BSc (Hons) in Applied Biology and as a Fellow of the Royal Society of Biology, Roger is committed to advanced dermatological science and translating evidence-based technologies into meaningful improvements in skin health. His focus is on supporting healthcare professionals, skin specialists, patients, and consumers with credible, clinically grounded information.
Since 2008, Ferndale Pharma has proudly served as the exclusive UK partner for Cantabria Labs, leaders in dermatological research, innovation, and advanced skincare technologies.
Lianne Sykes – Founder and Creative Director of Quirky Frog, a specialist marketing and PR agency dedicated to the medical aesthetics sector. With more than 15 years of experience in sales, marketing and brand strategy, she works closely with clinics and aesthetic brands to drive visibility, credibility and sustainable commercial growth.
Having built Quirky Frog into one of the UK’s leading specialist aesthetics marketing agencies, Lianne now leads a team supporting clinics and brands nationwide. She is a recognised industry speaker and educator, known for translating marketing, data insights and emerging technologies into practical strategies that help practitioners attract the right patients, strengthen their reputation and grow with confidence.
Cancellation Policy: If you can no longer attend, please let us know as soon as possible. We understand that plans can change, and we’ll always do our best to help. Refunds will be considered on a case-by-case basis, and wherever possible we’ll provide a full refund or offer an alternative if you’re unable to attend.